Unlock instant, AI-driven research and patent intelligence for your innovation.

Use of vgii3 activity modulator for the modulation of adipogenesis

a technology of adipogenesis and activity modulator, which is applied in the field of vgll, can solve the problems of limited fat storage capacity in adipose tissue, excess of this capacity, and accumulation of lipids in other tissues, and achieve the effect of reducing visceral and/or subcutaneous fat accumulation

Inactive Publication Date: 2015-03-05
SANOFI SA
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent describes a new invention that provides a composition containing a molecule that enhances the activity of a gene called Vgll3, and a safe substance. This composition can be made into a medicine to reduce the formation of fat cells in humans, treating obesity and related diseases. It can also help reduce the buildup of fat in the abdomen and the subcutaneous tissue.

Problems solved by technology

Storage of fat in adipose tissue is limited and exceeding this capacity leads to accumulation of lipids in others tissues, in particular in muscle, liver, and the endocrine pancreas, and to the secretion by adipocytes of various adipokines.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of vgii3 activity modulator for the modulation of adipogenesis
  • Use of vgii3 activity modulator for the modulation of adipogenesis
  • Use of vgii3 activity modulator for the modulation of adipogenesis

Examples

Experimental program
Comparison scheme
Effect test

example 1

Microarray Results

[0080]Bioinformatic analysis of the microarray data was performed to identify genes that fulfilled the three following criteria: (i) regulated by high fat feeding, (ii) similar regulated expression by high fat feeding in both visceral and subcutaneous fat and (iii) similar normalization of their expression by Rimonabant treatment (FIGS. 1A-B). Out of the ˜17′000 gene targets present on the cDNA microarray used, 34 genes fulfilled these criteria, which are listed in Table 1. Remarkably, 10 of these genes—Cav1, Fgf1, Fndc3b, Kif5b, Mest, Npr3, Pik3ca, Sparc, Vldlr, and Wwtr1—were previously known to be important regulators of adipose tissue development and function. Some of these genes had expression levels correlated with body weight gain (shown in grey in Table 1), suggesting a potential role in hyperplasia and / or hypertrophy of adipose tissues during obesity. These results validate the approach used to identify possible novel targets for therapeutic treatment of o...

example 2

Tissue and Cellular Expression of the Selected Genes

[0083]To better understand the role of Vgll3 in adipocytes development, its pattern of expression was first characterized. mRNA levels were measured by RT-PCR in various mouse tissues, in isolated preadipocytes and adipocytes, in visceral adipose tissue (VAT) and subcutaneous adipose tissue (SCAT) of mouse obesity model (Ob / Ob mice) and in human adipose tissues.

[0084]Vgll3 is highly expressed in kidney compared to other organs. It has a similar expression in VAT, SCAT, muscle and heart. The lowest expression is observed in liver, BAT and spleen. Vgll3 levels are normalized with cyclophilin A levels for each tissue and are expressed as relative fold increase compared to the liver level set arbitrarily at 1 (FIG. 2A).

[0085]Adipose tissue is a complex tissue that includes not only mature adipocytes, but also precursor cells such as preadipocytes as well as blood vessels, macrophages and fibroblastic cells. Based on a collagenase I dig...

example 3

Expression of Selected Genes During 3T3-L1 Differentiation

[0090]Next, the expression of Vgll3 gene was assessed during adipogenesis. For that purpose, mRNA levels were measured by RT-PCR during a detailed differentiation time-course of 3T3-L1 (an adipogenic cell line) (FIG. 2E). Interestingly, Vgll3 expression is decreased as soon as the DMI is added to the cells, and remains at very low levels during all 7 days, further suggesting that this gene is specifically down regulated to allow adipogenesis.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
resistanceaaaaaaaaaa
defectsaaaaaaaaaa
body weightaaaaaaaaaa
Login to View More

Abstract

The present invention concerns Vgll3 a new target involved in adipogenesis modulation.Further, the present invention relates to methods to increase Vgll3 activity in adipocytes and preadipocytes. In addition, pharmaceutical composition comprising Vgll3 activity enhancing molecules in order to enhance the Vgll3 activity in a target tissue are also provided. These methods, compositions and molecules can be useful to modulate adipogenesis and thus treat obesity and related disorders.

Description

BACKGROUND OF THE INVENTION[0001]The present invention concerns Vgll3 a new target involved in adipogenesis modulation.[0002]Further, the present invention relates to methods to increase Vgll3 activity in adipocytes and preadipocytes. In addition, pharmaceutical compositions comprising a molecule for enhancing Vgll3 activity in a target tissue are also provided. These methods, compositions and molecules can be useful to modulate adipogenesis and thus treat obesity and related disorders.[0003]Obesity is a major risk factor for a number of disorders including hypertension, coronary artery disease, dyslipidemia, insulin resistance and type 2 diabetes. Because of the importance of the obesity epidemic, a great deal of investigation has centered on the biology of the adipocyte, including the developmental pathway by which new adipocytes are created. Adipogenesis is the process by which undifferentiated mesenchymal precursor cells become mature adipocytes. Throughout the last decade consi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C12N15/63C12Q1/68
CPCC12N15/63C12Q2600/136C12Q1/6876A61K38/1709A61P3/00A61P3/04C07K14/4702G01N33/6872G01N2800/044A61K48/005C07K14/46C12N2800/107G01N33/53
Inventor HALL, DIANAJIMENEZ, MARIAPOUSSIN, CARINETHORENS, BERNARD
Owner SANOFI SA